63 related articles for article (PubMed ID: 2689665)
1. [Growth factors in prostatic cancer].
Wada F
Gan No Rinsho; 1989 May; Spec No():253-60. PubMed ID: 2689665
[No Abstract] [Full Text] [Related]
2. Expression of androgen receptor and growth factors in premalignant lesions of the prostate.
Harper ME; Glynne-Jones E; Goddard L; Mathews P; Nicholson RI
J Pathol; 1998 Oct; 186(2):169-77. PubMed ID: 9924433
[TBL] [Abstract][Full Text] [Related]
3. Heparin binding affinity of rat prostatic growth factor in normal and cancerous prostates: partial purification and characterization of rat prostatic growth factor in the Dunning tumor.
Matuo Y; Nishi N; Matsui S; Sandberg AA; Isaacs JT; Wada F
Cancer Res; 1987 Jan; 47(1):188-92. PubMed ID: 3791206
[TBL] [Abstract][Full Text] [Related]
4. Keratinocyte growth factor expression in hormone insensitive prostate cancer.
Leung HY; Mehta P; Gray LB; Collins AT; Robson CN; Neal DE
Oncogene; 1997 Aug; 15(9):1115-20. PubMed ID: 9285567
[TBL] [Abstract][Full Text] [Related]
5. Endothelin-1 production and decreased endothelin B receptor expression in advanced prostate cancer.
Nelson JB; Chan-Tack K; Hedican SP; Magnuson SR; Opgenorth TJ; Bova GS; Simons JW
Cancer Res; 1996 Feb; 56(4):663-8. PubMed ID: 8630991
[TBL] [Abstract][Full Text] [Related]
6. [Growth factors and neurotrophic factors with relevance to gliomas].
Nagashima T
No To Shinkei; 1997 Mar; 49(3):214-26. PubMed ID: 9125727
[No Abstract] [Full Text] [Related]
7. The effect of bone-associated growth factors and cytokines on the growth of prostate cancer cells derived from soft tissue versus bone metastases in vitro.
Lee HL; Pienta KJ; Kim WJ; Cooper CR
Int J Oncol; 2003 Apr; 22(4):921-6. PubMed ID: 12632088
[TBL] [Abstract][Full Text] [Related]
8. Bone microenvironment-related growth factors, zoledronic acid and dexamethasone differentially modulate PTHrP expression in PC-3 prostate cancer cells.
Tenta R; Sourla A; Lembessis P; Luu-The V; Koutsilieris M
Horm Metab Res; 2005 Oct; 37(10):593-601. PubMed ID: 16278781
[TBL] [Abstract][Full Text] [Related]
9. Steroid hormones, polypeptide growth factors, hormone refractory prostate cancer, and the neuroendocrine phenotype.
Evangelou AI; Winter SF; Huss WJ; Bok RA; Greenberg NM
J Cell Biochem; 2004 Mar; 91(4):671-83. PubMed ID: 14991759
[TBL] [Abstract][Full Text] [Related]
10. Exogenous fibroblast growth factors maintain viability, promote proliferation, and suppress GADD45alpha and GAS6 transcript content of prostate cancer cells genetically modified to lack endogenous FGF-2.
Shain SA
Mol Cancer Res; 2004 Nov; 2(11):653-61. PubMed ID: 15561781
[TBL] [Abstract][Full Text] [Related]
11. The trophic cocktail made by adrenal chromaffin cells.
Unsicker K
Exp Neurol; 1993 Oct; 123(2):167-73. PubMed ID: 7691649
[TBL] [Abstract][Full Text] [Related]
12. Differences in responsiveness of clonally derived AXC/SSh rat prostate cancer cells to secreted or prototypic mitogens.
Shain SA; Koger JD
Cancer Res; 1989 Jul; 49(14):3898-903. PubMed ID: 2786746
[TBL] [Abstract][Full Text] [Related]
13. Regulation of prostatic growth and function by peptide growth factors.
Culig Z; Hobisch A; Cronauer MV; Radmayr C; Hittmair A; Zhang J; Thurnher M; Bartsch G; Klocker H
Prostate; 1996 Jun; 28(6):392-405. PubMed ID: 8650077
[TBL] [Abstract][Full Text] [Related]
14. Androgens regulate vascular endothelial growth factor content in normal and malignant prostatic tissue.
Joseph IB; Nelson JB; Denmeade SR; Isaacs JT
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2507-11. PubMed ID: 9815654
[TBL] [Abstract][Full Text] [Related]
15. Potentiation of the antiangiogenic ability of linomide by androgen ablation involves down-regulation of vascular endothelial growth factor in human androgen-responsive prostatic cancers.
Joseph IB; Isaacs JT
Cancer Res; 1997 Mar; 57(6):1054-7. PubMed ID: 9067270
[TBL] [Abstract][Full Text] [Related]
16. [Role of intracellular calcium in the programmed cell death of prostatic cancer cells].
Tombal B; Gailly P; Van Cangh PJ; Gillis JM
Acta Urol Belg; 1995 Mar; 63(1):1-5. PubMed ID: 7537010
[TBL] [Abstract][Full Text] [Related]
17. Keratinocyte growth factor and fibroblast growth factor action on DNA synthesis in rat and human hepatocytes: modulation by heparin.
Strain AJ; McGuinness G; Rubin JS; Aaronson SA
Exp Cell Res; 1994 Feb; 210(2):253-9. PubMed ID: 7507851
[TBL] [Abstract][Full Text] [Related]
18. Development and characterization of DP-153, a nontumorigenic prostatic cell line that undergoes malignant transformation by expression of dominant-negative transforming growth factor beta receptor type II.
Song K; Cornelius SC; Danielpour D
Cancer Res; 2003 Aug; 63(15):4358-67. PubMed ID: 12907605
[TBL] [Abstract][Full Text] [Related]
19. Oligodendrocytes as providers of growth factors.
Du Y; Dreyfus CF
J Neurosci Res; 2002 Jun; 68(6):647-54. PubMed ID: 12111826
[TBL] [Abstract][Full Text] [Related]
20. [Signal transduction of growth factor mediated by heparin/heparan sulfate].
Iwasaki W; Inagaki F
Tanpakushitsu Kakusan Koso; 2001 Oct; 46(13):1922-8. PubMed ID: 11593742
[No Abstract] [Full Text] [Related]
[Next] [New Search]
